Animal models of nonalcoholic fatty liver disease and steatohepatitis

Clinics in Liver Disease

Volumn 8, Issue 3, 2004, Pages 559-574

  Nanji, Amin A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; FISH OIL; FRUCTOSE; LEPTIN; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT5 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; SUCROSE;

AMINO ACID DEFICIENCY; CALORIC INTAKE; DISEASE MODEL; GENETICS; LIPID DIET; LIPOGENESIS; METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATION; PEROXISOME; PROTEIN FUNCTION; REVIEW;

ANIMALS; DIETARY CARBOHYDRATES; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 4344617997     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.04.002     Document Type: Review

References (86)

1. Reid A. Nonalcoholic steatohepatitis. Gastroenterology. 121:2001;710-723
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 346:2002;1221-1230
3. Fong D.G., Nehra V., Lindor K.D., Buchman A.I. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology. 32:2000;3-10
4. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology. 122:2002;1649-1657
5. Koteish A., Diehl A.M. Animal models of steatosis. Semin Liver Dis. 21:2001;89-104
6. Clarke S.D. Nonalcoholic steatosis and steatohepatitis: 1. molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol. 281:2001;G865-G869
7. Bray G.A., Lovejoy G.A., Smith S.R., Delany G.P., Lefevre M., Hwang D., et al. The influence of different fats on obesity. Insulin resistance and inflammation. J Nutr. 132:2002;2488-2491
8. Duplus E., Glorian M., Forest C. Fatty acid regulation of gene transcription. J Biol Chem. 275:2000;30749-30752
9. Jump D.B., Clarke S.D. Regulation of gene expression by dietary fat. Annu Rev Nutr. 19:1999;63-90
10. Unger R.H. The physiology of cellular liporegulation. Annu Rev Physiol. 65:2003;333-347
11. Day C.P., James O.E.W. Hepatic steatosis: innocent bystander or guilty party. Hepatology. 1998;1463-1466
12. Listberger L.L., Han X., Lewis S.E., Cases S., Farese R.V., Ory D.S., et al. Triglyceride accumulation protects against fatty induced lipotoxicity. Proc Natl Acad Sci U S A. 100:2003;3077-3082
13. West D.B., York B. Dietary fat, genetic predisposition and obesity. Lessons from animal models. Am J Clin Nutr. 67:1998;505S-512S
14. Cha M.C., Chou C.J., Boozer C.N. High fat feeding reduces the diurnal variation of plasma leptin concentration in rats. Metabolism. 49:2000;503-507
15. Hill J.O., Lin D., Yakubu F., Peters J.C. Development of dietary obesity in rats, influence of amount and composition of dietary fat. Int J Obes Relat Metab Disord. 16:1992;321-333
16. Schemmel R., Mickelson O., Gill G.L. Dietary obesity in rats; body weight and body fat accretion in seven strains. J Nutr. 100:1970;1041-1048
17. Bray G.A., Lovejoy J.C., Smith S.R., Delany J.P., Levefre M., Hwang D., et al. The influence of dietary fats and fatty acids in obesity, insulins, resistance and inflammation. J Nutr. 132:2002;2488-2491
18. Lieber S.C., Leo M.A., Mak K.M., Su Y., Cao Q., Ren C., et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 79:2004;502-509
19. Angulo P., Lindor K.D. Insulin resistance and mitochondrial abnormalities in NASH: a cool look at a burning issue. Gastroenterology. 120:2001;1281-1285
20. Poulsom R. Morphological changes of organs after sucrose or fructose feeding prog. Biochem Pharmacol. 21:1986;104-134
21. Bogin E., Avidar Y., Meron M. Biochemical changes in liver and blood during liver fattening in rats. J Clin Chem Clin Biochem. 24:1986;621-626
22. Feldstein A.E., Canbay A.E., Giucciardi M.E., Higuchi H., Gores G.J. Hepatic steatosis enhances Fas expression and liver injury in mice [abstract]. Hepatology. 38:2003;192a
23. 2. J Pathol. 142:1993;367-373
24. Nanji A.A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., et al. Activation of nuclear factor kappa b and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology. 30:1999;934-943
25. Nanji A.A., Jokelainen K., Fotouhinia M., Rahemtulla A., Thomas P., Tipoe G.L., et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin and chemokines. Am J Physiol Gastrointest Liver Physiol. 281:2002;G1348-G1356
26. Nanji A.A., Miao L., Thomas P., Rahemtulla A., Khwaja S., Zhao S., et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 112:1997;943-951
27. Zeisel S.H., Blusztajn J.K. Choline and human nutrition. Annu Rev Nutr. 14:1994;269-296
28. Leclerg L.A., Farrell G.C., Field J., Bell D.R., Gonzalez F.J., Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest. 105:2000;1067-1075
29. Nanji A.A. Alcoholic liver disease. Zakim D., Boyer T.D. Hepatology: a textbook of liver disease. 4th edition:2003;839-922 Saunders, Philadelphia
30. Robertson G., Leclerq I., Farrell G.C. Nonalcoholic steatosis and steatohepatitis II: cytochrome P450 and oxidative stress. Am J Physiol Gastrointest Liver Physiol. 281:2001;G1135-G1139
31. Ip E., Farrell G.C., Robertson G.C., Hall P., Kirsch R., Leclerq I. Central Role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology. 38:2003;123-132
32. -1: a possible role for lipotoxicity in the pathogenesis of MCD induced steatohepatitis [abstract]. Hepatology. 34:2003;713A
33. Walkley C.J., Yu L., Agellon D.E., Vance D.E. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem. 273:1998;27043-27046
34. Zhu X., Song J., Mar M., Edwareds L.J., Zeisel S.H. Phosphakidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem J. 370:2003;987-993
35. Lu S.C., Alvarez L., Huang Z., Chen L., An W., Corrales L., et al. Methionine adenosyltransferase 1a knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A. 89:2001;5560-5565
36. Martinez-Mantar M.L., Corrales F.J., Martinez Cruz L.A., Trevijano E.R., Huang Z., Chen L., et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1a. FASEB J. 16:2002;1292-1294
37. Santamaria E., Avila M.A., Latasa M.U., Rubio A., Martin-Duce A., Lu S.C., et al. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S - adenosylmethionine. Proc Natl Acad Sci U S A. 100:2003;3065-3070
38. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human hemologue. Nature. 372:1994;425-432
39. Unger R.H. Leptin physiology: a second look. Regul Pept. 92:2000;87-95
40. Unger R.H., Zhou Y.T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A. 96:1999;2327-2332
41. Unger R.H. Lipotoxic diseases. Annu Rev Med. 53:2002;319-336
42. Ogus S., Ke Y., Qiu J., Wang B., Chehab F.F. Hyperleptinemia precipitates diet-induced obesity in transgenic mice overexpressing leptin. Endocrinology. 144:2003;2866-2869
43. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 94:1997;2557-2562
44. Rashid A., Wu T.C., Huang C.C., Chen C.H., Lin H.Z., Yang S.Q., et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in the mouse fatty liver. Hepatology. 29:1999;1131-1138
45. Chavin K.D., Yang S.Q., Lin Z., Chatham J., Chacko V.P., Hoek J.B., et al. Obesity induces expression of uncoupling protein 2 in hepatocytes and promotes liver ATP depletion. J Biol Chem. 274:1999;5692-5700
46. Desvergne B., Wahli W. Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocr Rev. 20:1999;649-688
47. Bocher V., Pineda I., Fruchart C., Staels B. PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann N Y Acad Sci. 967:2002;7-18
48. Reddy J.K. Nonalcoholic steatosis and steatohepatitis: peroxisomal β oxidation, PPAR and steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 281:2001;G1333-G1339
49. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. Peroxisome proliferator-activated receptorα mediates the adaptive response to fasting. J Clin Invest. 103:1999;1489-1498
50. Leone T., Weinheimer C., Kelly D. The critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPAR_ null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 96:1999;7473-7478
51. Costet P., Legendre C., More J., Edgar A., Galtier P., Pineau T. Peroxisome proliferator-activated receptor α isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem. 273:1998;29577-29585
52. 4 pathway to inflammation. Nature. 384:1996;39-43
53. Reddy J.K., Hashimoto T. Peroxisomal β oxidation and peroxisome proliferator-activated receptor-activated receptor: an adaptive metabolic system. Annu Rev Nutr. 21:2001;193-230
54. Fan C., Pan J., Chu R., Lee D., Kluckman D., Usuda N., et al. Hepatocellular and hepatic peroxisomal alternations in mice with a disrupted peroxisomal fatty acyt-coenzyme A oxidase gene. J Biol Chem. 271:1996;24698-24710
55. Hashimoto T., Fujita T., Usuda N., Cook W., Qi C., Peters J.M., et al. Peroxisomal and mitochondrial fatty acid β oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty Acyl-coA Oxidase. J Biol Chem. 274:1999;19228-19236
56. Chawla A., Shwarz E.J., Dimaculagan D.D., Lazar M.A. Peroxisome proliferator-activated receptor gamma: adipose predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:1994;798-800
57. Rocher V., Pineda-Torra I., Fruchart J.C., Staels B. PPARs transcription factors controlling lipid and lipoprotein metabolism. Ann N Y Acad Sci. 967:2002;7-18
58. Pekers J.M., Rusyn I., Rose M.L., Gonzalez F.J., Thurman R.G. Peroxisome-proliferator-activated alpha is restricted to hepatic parenchymal cells, not kupfter cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis. 21:2000;823-826
59. Memon R.A. Up-regulation of peroxisome proliferator-activated receptors, PPAR-alpha and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-response adipose tissue specific genes in the liver of obese diabetic mice. Endocrinology. 141:2000;4021-4031
60. Rahimian R., et al. Hepatic overexpression of peroxisome proliferator-activated receptor gamma in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem. 224:2001;29-37
61. Gavrilova O., Haluzik M., Matsuesue K., Gutson J.J., Johnson L., Dietz K.H., et al. Liver peroxisome proliferator-activated receptor γ clearance and regulation of body mass. J Biol Chem. 278:2003;34268-34276
62. Matsuesue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., et al. Liver-specific description of PPAR γ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotype. J Clin Invest. 111:2003;737-747
63. He W., Barak Y., Hevener A., Olson K., Liao D., Le J., et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A. 100:2003;15712-15717
64. Horton J.D., Shimomura I. Sterolan regulatory element binding proteins; activation of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol. 10:1999;143-150
65. Edwards P.A., Tabor D., Kast H.R., Venkateswaran A. Regulation of gene expression b SREBP and SCAP. Biochim Biophys Acta. 1529:2000;103-113
66. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis. J Clin Invest. 109:2002;1125-1131
67. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice overexpressing truncated SREBP-1a. J Clin Invest. 98:1996;1575-1584
68. Shimonura I., Shimano H., Korn B.S., Bashmaleov Y., Horton J.D. Nuclear sterol regulatory binding proteins activate genes for entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem. 273:1998;35299-35306
69. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform la in livers of transgenic mice and in cultured cells. J Clin Invest. 99:1997;846-854
70. Shimomura I., Bashmakov Y., Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mice models of diabetes mellitus. J Biol Chem. 274:1999;30028-30032
71. Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J., Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest. 101:1998;2331-2339
72. Darnell J.E. Stats and gene regulation. Science. 277:1997;1630-1635
73. Udy G.B., Towers R.P., Snell R.G., Wilkin R.J., Parks S., Ram P.A., et al. Requirement of STAT 5b for sexual dimorphism of body growth rats and liver gene expression. Proc Natl Acad Sci U S A. 94:1997;7239-7244
74. Davey H.W., McLachlan M.J., Wilkins R.J., Hilton D.J., Adams T.E. STAT 5b mediates the GH-induced expression of SOCS-2 and SOCS-3mRNA in the liver. Mol Cell Endocrinol. 158:1999;111-117
75. Sollars V.E., McEntice B.J., Engiles J.B., Rolkstein J.L., Buchberg A.M. A novel transgenic line of mice exhibiting autosomal recessive male-specific lethality and nonalcoholic fatty liver disease. Hum Mol Genet. 11:2002;2777-2786
76. Kroon F., Krosl J., Thorsteinsclottir U., Baban S., Buchberg A.M., Sauvageau G. Hox 9 transforms primary bone marrow cells through specific collaboration with Meis 1a but not Pbδclb. EMBO J. 17:1998;3714-3725
77. Pessayre D., Berson A., Fronmenty B., Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis. 21:2001;57-69
78. Fromenty B., Pessayre D. Inhibition of mitochondrial β oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 67:1995;101-154
79. Shellness G.S., Ingram M.F., Huang X.F., DeLozier J.A. Apolipoprotein β in the Rough endoplasmic reticulum: translation. Translocation and the initiation of lipoprotein assembly. J Nutr. 129:1999;456S-462S
80. Letteron P., Sutton A., Mansouri A., Fromenty B., Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 38:2003;133-140
81. Raabe M., Veniant M.M., Sullivan M.A., Zlot C.H., Bjorkegren J., Nielsen L.B., et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest. 103:1999;1287-1298
82. Sharp D., Blinderman L., Combs K.A., Kienzle B., Ricci B., Wager-Smith K., et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature. 365:1993;65-69
83. Perlemuter G., Sabile A., Letteron P., Vona G., Topilko A., Samson-Bouma M.E., et al. Hepatitis virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 16:2002;185-194
84. Bellringer M.E., Rahman K., Coleman R. Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes. Biochem J. 249:1988;513-519
85. Pariza M.W., Park Y., Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 40:2001;283-296
86. DeGrace P., Demizieux L., Gresti J., Chardigny J., Sebedio J., Clouet P. Association of liver steatosis with lipid oversecretion and hypotriglyceridemia in C57BL/6j mice fed trans-10, Cis-12 linoleic acid. FEBS Lett. 546:2003;335-339